nitrofurantoin / Generic mfg. 
Welcome,         Profile    Billing    Logout  
 0 Diseases   20 Trials   20 Trials   1189 News 


«12...9101112131415161718192021»
  • ||||||||||  nitrofurantoin / Generic mfg.
    Preclinical, Journal:  In Vitro and In Vivo Trypanocidal Efficacy of Synthesized Nitrofurantoin Analogs. (Pubmed Central) -  Jul 14, 2021   
    In vivo experiments, involving oral treatment with nitrofurantoin, showed partial efficacy, whereas the selected analogs showed no treatment efficacy. These results indicate that nitrofurantoin analogs with high hydrophilicity are required for in vivo assessment to determine if they are promising leads for developing trypanocidal drugs.
  • ||||||||||  ampicillin / Generic mfg., amoxicillin / Generic mfg.
    Journal:  Characterization of Escherichia coli D7111 producing the β-LACTAMASE TEM-176. (Pubmed Central) -  Jul 8, 2021   
    Quinolone resistance was related to the substitution Ser83Ala. The TEM sequencing showed the presence of the new substitution Ala222Val, which led to the description of the new β-lactamase bla TEM-176.
  • ||||||||||  ceftriaxone / Generic mfg., ampicillin / Generic mfg., cefuroxime / Generic mfg.
    Journal:  Antimicrobial resistance patterns among different Escherichia coli isolates in the Kingdom of Saudi Arabia. (Pubmed Central) -  Jul 6, 2021   
    The air sample isolates were most resistant to amoxicillin, ampicillin, amoxicillin/clavulanic acid, amoxicillin/sulbactam, piperacillin/tazobactam, cefalotin, cefuroxime, cefoxitin, cefixime, nitrofurantoin, and trimethoprim/sulfamethoxazol...The isolates from the human urine samples were most frequently resistant to norfloxacin (80%) followed by amoxicillin and ampicillin (70%), trimethoprim/sulfamethoxazole (55%), ciprofloxacin and ofloxacin (50%), cefalotin (30%), cefuroxime, cefixime and cefotaxime (25%), ceftazidime, ceftriaxone, cefepime and aztreonam (20%), amoxicillin/clavulanic acid, piperacillin/tazobactam and gentamicin (10%), and amoxicillin/sulbactam and cefoxitin (5%)...The quinolone resistance gene qnrS was detected in 25% (n = 6) of the E. coli strains isolated from urine (N = 5) and air (N = 1) samples. The considerable number of antimicrobial resistance genes detected among E. coli isolates tested here is alarming and should raise public health concern.
  • ||||||||||  ceftriaxone / Generic mfg.
    Review, Journal:  Antimicrobial resistance among uropathogens in the Asia-Pacific region: a systematic review. (Pubmed Central) -  Jul 6, 2021   
    Resistance against nitrofurantoin ranged between 2.7% and 31.4%...We show very high prevalence estimates of AMR against antibiotics commonly used for the empirical treatment of UTI, in the limited number of countries in the APAC for which data are available. Novel feasible and affordable approaches that facilitate population-based AMR surveillance are needed to increase knowledge on AMR prevalence across the region.
  • ||||||||||  nitrofurantoin / Generic mfg.
    [VIRTUAL] A case of secondary syphilis resembling erythema multiforme: how histopathology clues can avoid a delayed diagnosis () -  Jul 5, 2021 - Abstract #BAD2021BAD_253;    
    Based on a recent history of nitrofurantoin ingestion, a clinical diagnosis of erythema multiforme was made...Early recognition and treatment of syphilis is vital in limiting progression to the tertiary stage, which has a higher morbidity and mortality owing to its neurological and cardiovascular sequelae. Histopathology provides useful clues and pattern recognition helps to prompt serological testing and avoid diagnostic delay.
  • ||||||||||  ceftriaxone / Generic mfg., ampicillin / Generic mfg.
    Retrospective data, Review, Journal:  Group B streptococcus drug resistance in pregnant women in Iran: a meta-analysis. (Pubmed Central) -  Jul 2, 2021   
    Additionally, resistance to penicillin (4.2%), ampicillin (2.7%), cefazolin (7.6%), vancomycin (2.4%), ceftriaxone (12.5%), ciprofloxacin (13.6%) and nitrofurantoin (0%) was low. Our results revealed that penicillin and ampicillin among penicillin-tolerant Iranian pregnant women, and vancomycin and cefazolin among penicillin-allergic women are still drugs of choice in intrapartum prophylaxis for preventing S. agalactiae vertical transmission and early-onset neonatal disease.
  • ||||||||||  ampicillin / Generic mfg.
    Clinical, Retrospective data, Journal:  Evaluation of sensitivity profiles to fosfomycin in bacterial urine samples from outpatients. (Pubmed Central) -  Jul 1, 2021   
    The microbiological profile established here shows substantial sensitivity to fosfomycin in the urine samples analysed. In most cases, there was a sensitivity profile that was favourable to the use of fosfomycin or at least comparable to the other antibiotics studied.
  • ||||||||||  cefazolin / Generic mfg., trimethoprim/sulfamethoxazole / Generic mfg., nitrofurantoin / Generic mfg.
    Retrospective data, Journal:  Fluoroquinolone resistance in Escherichia coli isolates after exposure to non-fluoroquinolone antibiotics: a retrospective case-control study. (Pubmed Central) -  Jun 26, 2021   
    Assuming no residual confounding or other biases, this study suggests that exposure to non-fluoroquinolone antibiotics, i.e. trimethoprim/sulfamethoxazole and nitrofurantoin, might be causally related to fluoroquinolone resistance in E. coli isolates from urinary samples. Future prospective research is needed to confirm non-fluoroquinolone antibiotics as potential drivers of fluoroquinolone resistance.
  • ||||||||||  ceftriaxone / Generic mfg.
    Clinical, Journal:  Antibiotic resistance: a comparison between inpatient and outpatient uropathogens. (Pubmed Central) -  Jun 26, 2021   
    Uropathogen resistant rates in inpatients were higher than outpatient rates. The use of imipenem and amikacin instead of traditional first-line empirical therapy (fluoroquinolone and sulfamethoxazole-trimethoprim) is advised for hospitalized patients with urinary tract infections.
  • ||||||||||  nitrofurantoin / Generic mfg.
    Journal:  Novel particles conferring eradication of deep tissue bacterial reservoirs for the treatment of chronic urinary tract infection. (Pubmed Central) -  Jun 22, 2021   
    This work investigates the use of nitrofurantoin loaded poly(lactic-co-glycolic acid) (PLGA) particles to improve delivery to intracellular targets for the treatment of chronic UTI...These results illustrate the potential for using antibiotic-loaded microparticles to effectively treat chronic UTIs. Such a delivery method could be extrapolated to other clinical indications where robust intracellular delivery is required, such as oncology and gene therapy.
  • ||||||||||  trimethoprim/sulfamethoxazole / Generic mfg., nitrofurantoin / Generic mfg.
    Clinical, Journal:  Effect of continuous antibiotic prophylaxis in children with postoperative JJ stents: A prospective randomized study. (Pubmed Central) -  Jun 22, 2021   
    Such a delivery method could be extrapolated to other clinical indications where robust intracellular delivery is required, such as oncology and gene therapy. CAP in the presence of JJ stents reduced the incidence of febrile urinary tract infections in a short period, especially in children with the previous history of febrile urinary tract infections and lower urinary tract symptoms.
  • ||||||||||  nitrofurantoin / Generic mfg.
    Journal:  Metabolites potentiate nitrofurans in non-growing Escherichia coli. (Pubmed Central) -  Jun 22, 2021   
    Nitrofurantoin (NIT) is a broad-spectrum bactericidal antibiotic used in the treatment of urinary tract infections...In addition, we observed that NIT activity against stationary-phase uropathogenic E. coli (UPEC) could also be potentiated through metabolite supplementation. These findings suggest that the combination of nitrofurans with specific metabolites could improve the outcome of uncomplicated urinary tract infections (UTIs).
  • ||||||||||  amikacin sulfate / Generic mfg., nitrofurantoin / Generic mfg.
    Journal:  Nitrofurantoin Combined With Amikacin: A Promising Alternative Strategy for Combating MDR Uropathogenic Escherichia coli. (Pubmed Central) -  Jun 22, 2021   
    Importantly, amikacin or nitrofurantoin at half of the clinical doses were not effective in the treatment of UPEC infections in the G. mellonella model but the combination therapy significantly increased G. mellonella survival from infections caused by all 12 study UPEC strains. Taken together, these results demonstrated synergy effects between nitrofurantoin and amikacin against MDR UPEC.
  • ||||||||||  ciprofloxacin oral / Generic mfg., levofloxacin / Generic mfg., nitrofurantoin / Generic mfg.
    Journal:  Antioxidant molecules as a source of mitigation of antibiotic resistance genes dissemination. (Pubmed Central) -  Jun 22, 2021   
    Furthermore, we showed that some antioxidant molecules currently approved for unrelated clinical uses such as edaravone, p-Coumaric acid and N-acetylcysteine may antagonize the inducibility effect of antibiotics in term of increased plasmid conjugation rates. These results suggest that several antioxidative molecules might be used in combination with those "inducer" antibiotics to mitigate the unwanted increased resistance plasmid dissemination.
  • ||||||||||  nitrofurantoin / Generic mfg.
    [VIRTUAL] Employing DOZN™ 2.0 tool for mechanochemistry to assess risk () -  Jun 14, 2021 - Abstract #ACSGCE2021ACS_GCE_433;    
    DOZN™ 2.0 – MilliporeSigma’s Green Chemistry Evaluator tool was successfully employed the first time to mechanochemical synthesis of the Active Pharmaceutical Ingredient (API), nitrofurantoin in batch and in continuous processes via Twin Screw Extrusion. Advantages of DOZN™ 2.0 results will be presented.
  • ||||||||||  nitrofurantoin / Generic mfg.
    Preclinical, Journal:  Antibacterial properties and in vivo efficacy of a novel nitrofuran, IITR06144, against MDR pathogens. (Pubmed Central) -  Jun 10, 2021   
    The structurally similar antibiotics nitroxoline and nitrofurantoin appear to have different modes of action and resistance mechanisms. In the light of excellent in vitro properties displayed by IITR06144 coupled with its considerable in vivo efficacy, further evaluation of IITR06144 as a therapeutic lead against antibiotic-resistant infections is warranted.